4327-3206 Screening compound: 1-(10H-phenothiazin-10-yl)-2-[(1-propyl-1H-1,3-benzodiazol-2-yl)sulfanyl]ethan-1-one

4327-3206 Screening compound: 1-(10H-phenothiazin-10-yl)-2-[(1-propyl-1H-1,3-benzodiazol-2-yl)sulfanyl]ethan-1-one
4327-3206 Screening compound: 1-(10H-phenothiazin-10-yl)-2-[(1-propyl-1H-1,3-benzodiazol-2-yl)sulfanyl]ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound 4327-3206
1-(10H-phenothiazin-10-yl)-2-[(1-propyl-1H-1,3-benzodiazol-2-yl)sulfanyl]ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4327-3206

Molecular Formula

C24H21N3OS2 (C24 H21 N3 OS2)

Compound Name

1-(10H-phenothiazin-10-yl)-2-[(1-propyl-1H-1,3-benzodiazol-2-yl)sulfanyl]ethan-1-one

IUPAC name

1-(10H-phenothiazin-10-yl)-2-[(1-propyl-1H-13-benzodiazol-2-yl)sulfanyl]ethan-1-one

SMILES

CCCn1c(SCC(N2c(cccc3)c3Sc3c2cccc3)=O)nc2c1cccc2

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.056

Distribution Coefficient, logD

6.056

Water Solubility, LogSw

-5.53

Polar Surface Area

24.103

Acid Dissociation Constant (pKa)

17.31

Base Dissociation Constant (pKb)

2.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

4327-3206 in Drug Discovery

Included in Screening Libraries

CNS targets activity set (6557 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

Human GPCR Annotated Library (5539 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 4327-3206 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4327-3206?
Check Price and Availability of 4327-3206, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4327-3206 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4327-3206
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4327-3206
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4327-3206 available by request